Buscar resultados de ensayos clínicos
Lymphoma, B-Cell, Marginal Zone - 25 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: Prognostic Study of Gastric MALT Lymphoma After Eradication of Helicobacter Pylori Condición: Gastric Low-grade MALT Lymphoma With Helicobacter Pylori Positive Fecha: 2010-12-20 Intervenciones: Drug: Rabeprazole Sodium The following 3 drugs are taken o |
Completed |
Nombre del estudio: Velcade in MALT Lymphoma Patients Condición: MALT Lymphoma Fecha: 2006-09-07 Intervenciones: Drug: Bortezomib (Velcade) |
Completed |
Nombre del estudio: Multicenter Phase II Study to Evaluate the Clinical Activity and the Safety Profile of Everolimus in Marginal Zone B-cell Lymphomas (MZL) Condición: Marginal Zone B-cell Lymphoma Fecha: 2010-07-15 Intervenciones: Drug: Everolimus Everolimus (tablets, 5 mg) is given orally at the dose of 10 mg/day from day 1 to day 2 |
Active, not recruiting |
Nombre del estudio: Bendamustine and Rituximab for the Treatment of Splenic Marginal Zone Lymphoma Condición: Marginal Zone B-cell Lymphoma Fecha: 2016-07-26 Intervenciones: Drug: Bendamustine and Rituximab |
Terminated |
Nombre del estudio: Gemcitabine for Marginal Zone Lymphoma Condición:
Fecha: 2006-06-14 Intervenciones: Drug: gemcitabine D1 and 8, Gemcitabine 1250mg/m2 + NS 100ml MIV over 30min, every 3 weeks |
Active, not recruiting |
Nombre del estudio: Phase II Trial of First-line Doxycycline for Ocular Adnexal Marginal Zone Lymphoma Treatment Condición: Marginal Zone Lymphoma of Ocular Adnexal Fecha: 2013-03-26 Intervenciones: Drug: Doxycycline All enrolled patients will be treated with doxycycline 100 mg bid daily, orally, for f |
Active, not recruiting |
Nombre del estudio: 131I-rituximab for Relapsed or Refractory Marginal Zone B-cell Lymphoma Condición: Relapsed or Refractory Marginal Zone B-cell Lymphoma Fecha: 2012-09-04 Intervenciones: Drug: 131I-rituximab |
Completed |
Nombre del estudio: Prospective Study of First-line Antibiotic Therapy for Early-stage Gastric MALT Lymphoma for Treatment Outcome Condición: Gastric MALT Lymphoma Fecha: 2006-05-17 Intervenciones: Drug: Omeprazole, Amoxicillin, Clarithromycin |
Active, not recruiting |
Nombre del estudio: Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Relapsed/Refractory Marginal Zone Lymphoma Condición:
Fecha: 2013-10-29 Intervenciones: Drug: ibrutinib |
Terminated |
Nombre del estudio: Epigenetic Modulation in Relapsed/Refractory Follicular Lymphoma and Marginal Zone Lymphoma Condición:
Fecha: 2010-02-11 Intervenciones:
|